Recent developments in adjuvant chemotherapy for colorectal cancer.
Recent developments in the use of systemic chemotherapy and intraportal chemotherapy in the treatment for colorectal cancer suggests that a reduction in mortality is achievable. This paper provides an overview of the management of colorectal cancer and the rationale behind adjuvant chemotherapy. A review of the current research literature published from both America and Europe will follow. Finally, the limitations and implications of the reviewed data will be discussed.
Knowles
G H
GH
Imperial Cancer Research Fund, Department of Clinical Oncology, Western General Hospital, Edinburgh.
Jodrell
D I
DI
D000230:Adenocarcinoma / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D006801:Humans
D000970:Antineoplastic Agents